Current opinion on molecular characterization for GBM classification in guiding clinical diagnosis, prognosis, and therapy

P Zhang, Q Xia, L Liu, S Li, L Dong - Frontiers in molecular …, 2020 - frontiersin.org
Glioblastoma (GBM) is highly invasive and the deadliest brain tumor in adults. It is
characterized by inter-tumor and intra-tumor heterogeneity, short patient survival, and lack of …

Biomarkers and therapeutic advances in glioblastoma multiforme

AO Sasmita, YP Wong, APK Ling - Asia‐Pacific Journal of …, 2018 - Wiley Online Library
Glioblastoma multiforme (GBM) is a malignant tumor within the brain. Generally classified as
primary and secondary with several different subtypes, ample molecular biomarkers have …

Novel nano-drug delivery system for brain tumor treatment

Z Qiu, Z Yu, T Xu, L Wang, N Meng, H Jin, B Xu - Cells, 2022 - mdpi.com
As the most dangerous tumors, brain tumors are usually treated with surgical removal,
radiation therapy, and chemotherapy. However, due to the aggressive growth of gliomas …

Efficient gene transfer to the central nervous system by single-stranded Anc80L65

E Hudry, E Andres-Mateos, EP Lerner, A Volak… - … Therapy Methods & …, 2018 - cell.com
Adeno-associated viral vectors (AAVs) have demonstrated potential in applications for
neurologic disorders, and the discovery that some AAVs can cross the blood-brain barrier …

Towards clinical implementation of adeno-associated virus (AAV) vectors for cancer gene therapy: current status and future perspectives

UT Hacker, M Bentler, D Kaniowska, M Morgan… - Cancers, 2020 - mdpi.com
Adeno-associated virus (AAV) vectors have gained tremendous attention as in vivo delivery
systems in gene therapy for inherited monogenetic diseases. First market approvals …

Apoptosis-inducing TNF superfamily ligands for cancer therapy

OA Diaz Arguello, HJ Haisma - Cancers, 2021 - mdpi.com
Simple Summary Cancer is a complicated disease that has a significant characteristic of
evading cell death (apoptosis). The induction of apoptosis in cancerous cells seems a …

[HTML][HTML] Challenges in adeno-associated virus-based treatment of central nervous system diseases through systemic injection

L Huang, J Wan, Y Wu, Y Tian, Y Yao, S Yao, X Ji… - Life Sciences, 2021 - Elsevier
Adeno-associated virus (AAV) vector, an excellent gene therapy vector, has been widely
used in the treatment of various central nervous system (CNS) diseases. Due to the …

Systems biology approaches for the improvement of oncolytic virus-based immunotherapies

L Tripodi, E Sasso, S Feola, L Coluccino, M Vitale… - Cancers, 2023 - mdpi.com
Simple Summary This review provides a roadmap to develop safe and effective OV-based
future therapeutics by using several novel synthetic and system biology strategies …

New frontiers in oncolytic viruses: optimizing and selecting for virus strains with improved efficacy

K Lundstrom - Biologics: Targets and Therapy, 2018 - Taylor & Francis
Oncolytic viruses have demonstrated selective replication and killing of tumor cells. Different
types of oncolytic viruses–adenoviruses, alphaviruses, herpes simplex viruses, Newcastle …

Comparative study of neuron-specific promoters in mouse brain transduced by intravenously administered AAV-PHP. eB

PT Radhiyanti, A Konno, Y Matsuzaki, H Hirai - Neuroscience letters, 2021 - Elsevier
Abstract Adeno-associated virus (AAV)-PHP. B and AAV-PHP. eB (PHP. eB), a capsid
variant of AAV serotype 9, efficiently penetrates the mouse blood-brain barrier and …